Lakshmana Pendyala
About
Lakshmana Pendyala is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine.
According to data from OpenAlex, Lakshmana Pendyala has authored 65 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Surgery, 41 papers in Cardiology and Cardiovascular Medicine and 17 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Lakshmana Pendyala's work include Coronary Interventions and Diagnostics (34 papers), Cardiac Valve Diseases and Treatments (15 papers) and Antiplatelet Therapy and Cardiovascular Diseases (13 papers). Lakshmana Pendyala is often cited by papers focused on Coronary Interventions and Diagnostics (34 papers), Cardiac Valve Diseases and Treatments (15 papers) and Antiplatelet Therapy and Cardiovascular Diseases (13 papers). Lakshmana Pendyala collaborates with scholars based in United States, Australia and United Kingdom. Lakshmana Pendyala's co-authors include Ron Waksman, Jack P. Chen, Dongming Hou, Nicolas Chronos, Spencer B. King, Rebecca Torguson, Refat Jabara, Augusto D. Pichard, Sa’ar Minha and Lowell F. Satler and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and The American Journal of Cardiology.
In The Last Decade
Lakshmana Pendyala
62 papers receiving 1.3k citations
Peers
Lakshmana Pendyala
Ali Rıza Erbay Türkiye
Yoshitaka Sugawara Japan
Mackenzie Quantz Canada
Emil Missov United States
Selçuk Pala Türkiye
Masashi Fujino Japan
Chun‐Chi Chen Taiwan
Enrico Cerrato Italy
Si Wan Choi South Korea
Young Jin Youn South Korea
Citations per year, relative to Lakshmana Pendyala Lakshmana Pendyala (= 1×)
peers
Ali Rıza Erbay
Countries citing papers authored by Lakshmana Pendyala
Since
Specialization
Citations
This map shows the geographic impact of Lakshmana Pendyala's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lakshmana Pendyala with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lakshmana Pendyala more than expected).
Fields of papers citing papers by Lakshmana Pendyala
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Lakshmana Pendyala. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lakshmana Pendyala. The network helps show where Lakshmana Pendyala may publish in the future.
Co-authorship network of co-authors of Lakshmana Pendyala
This figure shows the co-authorship network connecting the top 25 collaborators of Lakshmana Pendyala. A scholar is included among the top collaborators of Lakshmana Pendyala based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lakshmana Pendyala. Lakshmana Pendyala is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Minha, Sa’ar, Itsik Ben‐Dor, Lakshmana Pendyala, et al.. (2014). DOES MILD AORTIC REGURGITATION IN PATIENTS POST-TRANSCATHETER AORTIC VALVE REPLACEMENT IMPACT MORTALITY?. Journal of the American College of Cardiology. 63(12). A1726–A1726.
2.
Baker, Nevin C., Michael J. Lipinski, Ricardo O. Escárcega, et al.. (2014). TCT-844 Active Versus Passive Anchoring Vascular Closure Devices: A Safety and Efficacy Comparative Analysis. Journal of the American College of Cardiology. 64(11). B246–B246.
3.
Ota, Hideaki, Lakshmana Pendyala, Joshua P. Loh, et al.. (2014). CRT-156 Current Perspectives on Stent Deformation: Trends, Characteristics and Outcomes From the Food and Drug Administration Manufacturer and User Facility Device Experience Database. JACC: Cardiovascular Interventions. 7(2). S2–S2.
4.
Pendyala, Lakshmana, Joshua P. Loh, Sa’ar Minha, et al.. (2014). CRT-158 Impact of Glycosylated Hemoglobin (HbA1C) Levels in Patients with Diabetes Mellitus Undergoing Percutaneous Coronary Intervention with Second Generation Drug-Eluting Stent Implantation. JACC: Cardiovascular Interventions. 7(2). S2–S2.
5.
Loh, Joshua P., Lowell F. Satler, Lakshmana Pendyala, et al.. (2014). Use of emergency medical services expedites in-hospital care processes in patients presenting with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Cardiovascular revascularization medicine. 15(4). 219–225.
6.
Lipinski, Michael J., Lakshmana Pendyala, Rebecca Torguson, Fang Chen, & Ron Waksman. (2014). Stent thrombosis is not increased following percutaneous coronary intervention in patients with non-insulin dependent diabetes mellitus taking metformin. Atherosclerosis. 235(2). 295–298.
7.
Kitabata, Hironori, Joshua P. Loh, Lakshmana Pendyala, et al.. (2014). Intra-stent tissue evaluation within bare metal and drug-eluting stents > 3 years since implantation in patients with mild to moderate neointimal proliferation using optical coherence tomography and virtual histology intravascular ultrasound. Cardiovascular revascularization medicine. 15(3). 149–155.
8.
Badr, Salem, Itsik Ben‐Dor, Israel M. Barbash, et al.. (2013). CRT-2 The State Of The Excimer Laser For Coronary Intervention In The Drug-eluting Stent Era. JACC: Cardiovascular Interventions. 6(2). S1–S1.
9.
Pendyala, Lakshmana, Rebecca Torguson, Joshua P. Loh, et al.. (2013). Comparison of Adverse Outcomes After Contemporary Percutaneous Coronary Intervention in Women Versus Men With Acute Coronary Syndrome. The American Journal of Cardiology. 111(8). 1092–1098.
10.
Loh, Joshua P., Lakshmana Pendyala, Hironori Kitabata, et al.. (2013). CRT-125 Do Second-Generation Drug-Eluting Stents Outperform First-Generation Drug-Eluting Stents When Used in “Full Metal Jacket” Percutaneous Coronary Intervention Procedures?. JACC: Cardiovascular Interventions. 6(2). S40–S41.
11.
Dvir, Danny, Israel M. Barbash, Itsik Ben‐Dor, et al.. (2013). Paravalvular regurgitation after transcatheter aortic valve replacement: Diagnosis, clinical outcome, preventive and therapeutic strategies. Cardiovascular revascularization medicine. 14(3). 174–181.
12.
Kitabata, Hironori, Joshua P. Loh, Lakshmana Pendyala, et al.. (2013). Two-Year Follow-Up of Outcomes of Second-Generation Everolimus-Eluting Stents Versus First-Generation Drug-Eluting Stents for Stenosis of Saphenous Vein Grafts Used as Aortocoronary Conduits. The American Journal of Cardiology. 112(1). 61–67.
13.
Badr, Salem, Itsik Ben‐Dor, Danny Dvir, et al.. (2013). The state of the excimer laser for coronary intervention in the drug-eluting stent era. Cardiovascular revascularization medicine. 14(2). 93–98.
14.
Pendyala, Lakshmana, Daisuke Matsumoto, Toshiro Shinke, et al.. (2012). Nobori Stent Shows Less Vascular Inflammation and Early Recovery of Endothelial Function Compared With Cypher Stent. JACC: Cardiovascular Interventions. 5(4). 436–444.
15.
Superko, H. Robert, et al.. (2012). High-density lipoprotein subclasses and their relationship to cardiovascular disease. Journal of clinical lipidology. 6(6). 496–523.
16.
Loh, Joshua P., Lakshmana Pendyala, Hironori Kitabata, et al.. (2012). Safety of Reloading Prasugrel in Addition to Clopidogrel Loading in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention. The American Journal of Cardiology. 111(6). 841–845.
17.
Pendyala, Lakshmana, et al.. (2010). ASYMPTOMATIC FIREFIGHTERS WITH METABOLIC SYNDROME HAVE A HIGH INCIDENCE OF BOTH CORONARY AND CAROTID PREMATURE ATHEROSCLEROSIS-ASSOCIATED WITH INCREASED THROMBOTIC AND INFLAMMATORY MARKERS. Journal of the American College of Cardiology. 55(10). A163.E1527–A163.E1527.
18.
Pendyala, Lakshmana, Jinsheng Li, Toshiro Shinke, et al.. (2009). Endothelium-Dependent Vasomotor Dysfunction in Pig Coronary Arteries With Paclitaxel-Eluting Stents Is Associated With Inflammation and Oxidative Stress. JACC: Cardiovascular Interventions. 2(3). 253–262.
19.
Pendyala, Lakshmana, et al.. (2009). The First-Generation Drug-Eluting Stents and Coronary Endothelial Dysfunction. JACC: Cardiovascular Interventions. 2(12). 1169–1177.
20.
Shinke, Toshiro, Lakshmana Pendyala, Refat Jabara, et al.. (2008). Low-dose paclitaxel elution by novel bioerodible sol-gel coating on stents inhibits neointima with low toxicity in porcine coronary arteries. International Journal of Cardiology. 135(1). 93–101.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Ali Rıza Erbay Breakdown of academic impact, for papers by Yoshitaka Sugawara Breakdown of academic impact, for papers by Mackenzie Quantz Breakdown of academic impact, for papers by Emil Missov Breakdown of academic impact, for papers by Selçuk Pala Breakdown of academic impact, for papers by Masashi Fujino Breakdown of academic impact, for papers by Chun‐Chi Chen Breakdown of academic impact, for papers by Enrico Cerrato Breakdown of academic impact, for papers by Si Wan Choi Breakdown of academic impact, for papers by Young Jin Youn